Toni Choueiri: Celebrating Matt Freedman, the new David Goldstein Chair at Dana-Farber Cancer Institute

Toni Choueiri shared on X:

“A beautiful night celebrating our friend/collaborator and scientist-extraordinaire Matt Freedman, the new David Goldstein Chair at Dana-Farber Cancer Institute. The Chair will focus on many aspects of Kidney Cancer Research.”

Source: Toni Choueiri/X

Toni Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School. He is the Medical Director of International Strategic Initiatives at Dana-Farber and past President of the Medical Staff at DFCI (2016-2018).

Dr. Matthew Freedman is the David Goldstein Chair at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School. He is also an Associate Member at the Broad Institute. His research primarily focuses on characterizing the non-coding genome, with a specific emphasis on investigating the epigenetic landscape of prostate cancer throughout its progression.